Impact of Rituximab in the Management of Pemphigus Vulgaris: A Case Report
DOI:
https://doi.org/10.61427/jcpr.v3.i4.2023.114Keywords:
Auto-antibodies, Blisters, Desmosomes, Lesions, Pemphigus VulgarisAbstract
The term “Pemphigus” is derived from the Greek word Pemphix means “bubble or blister” and Vulgaris means “common”. It is a potentially life-threatening disease that causes erosions and blisters of the skin and mucous membranes. It is a chronic, rare, intra-epidermal bullous disease with a potentially fatal outcome and was originally named by Wickman in the years 1791. Pemphigus is an uncommon disease with an incidence rate ranging from 0.5 to 3.2 per 100,000 per year. In this article, we discussed a rare case report on the impact of Rituximab in the management of Pemphigus Vulgaris. The Inj. Rituximab was found to be more effective in treating Pemphigus Vulgaris along with supportive medication. By considering different literature, it has been concluded that Pemphigus Vulgaris has a relapse in nature. So, ongoing monitoring and adjustment of treatment are often necessary to manage the condition. Patient must require regular follow-up appointments with his healthcare professional to monitor the disease actively and adjust the treatment as necessary depending upon their clinical manifestations.
Downloads
References
Shafer, Hine, Levy. Textbook of Oral Pathology 5th edition Neville, Damn, Allen, Bouquet. Textbook of Oral and Maxillofacial Pathology 2nd edition. Philadelphia 1995, saunders martin D Greenburg.Micheal Glick Burketts Orla medicine Diagnosis and treatment 10th edition.
Korman N. Pemphigus J. Am Acaddermat. 1998; 18; 1219-38.
Ahmed AR. Lymphocyte studies in Pemphigus. Arch Dermatol Res. 1998; 271: 111-5.
Pisanti S, Sharav Y, Kaufman E, Posner LN. Pemphigus vulgaris; the incidence in jews of different ethnic groups according to age sex and initial lesions. Oral path oral med. Oral Sug. 1974; 38(3); 382-7.
Vodo D, Sarig O, Sprecher E. The genetics of pemphigus Vulgaris. Front Med (Lausanne). 2018; 5: 226.
Melchionda V, Harman KE. Pemphigus vulgaris and pemphigus Foliaceus: an overview of the clinical presentation, investigations and management. Clin Exp Dermatol. 2019; 44(7):740-6.
Daltaban O, Ozçentik A, Akman Karaka? A, Ustun K, Hatipoglu M, Uzun S. Clinical presentation and diagnostic delay in pemphigus vulgaris: A prospective study from Turkey. J Oral Pathol Med. 2020; 49(7): 681-6.
Ali Y, Ali Reza, Gita F. Pemphigus vulgaris in Iran: Epidemiology and clinical profile. SKIN med, 2006; 5(2): 69–71.
Dagistan S, Goregen M, Miloglu, Çakur B. Oral pemphigus vulgaris: A case report with review of the literature, Journal of Oral Science, 2008; 50(3): 359-62.
Saito M, Stahley SN, Caughman CY, Mao X, Tucker DK, Payne AS, Amagai M, Kowalczyk AP. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation. PLoS ONE. 2012; 7: e50696.
Amagai M, Koch PJ, Nishikawa T, Stanley JR. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J. Investig. Dermatol. 1996; 106: 351-5.
Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J. Am. Acad. Dermatol. 1999; 40: 167-70.
Karpati S, Amagai M, Prussick R, Cehrs K, Stanley JR. Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes. J. Cell Biol. 1993; 122: 409-15.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Most read articles by the same author(s)
- Mukesh Kumar Saphi, Yalla Sai Vijaya Durga, Sunny Kumar Yadav, Krishnadev Shah, Amit Kumar, Plummer-Vinson Syndrome: A Rare Case Report , Journal of Clinical and Pharmaceutical Research: JCPR Volume:4/Issue:1 (2024)
.